AUPH Aurinia Pharmaceuticals Inc gains 48% Nov 9, 2021

Posted By: Rajesh Srivastava - Tuesday, November 09, 2021

Share

& Comment

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.http://www.priceseries.com/trade/AUPH-Aurinia-Pharmaceuticals-Inc-stock-gains-48-percent-a-Trade-Record-by-priceSeries-2021102020211109.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.